Dow Jones

38 807,33

0,25%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
AMEX
Synvista Therapeutics, (SYI)
Synvista Therapeutics, (SYI) Actualités

SYI

S.Y. Bancorp (SYI)

Synvista Therapeutics,

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:AMEX:SYI

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
16/03/2009	11h00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	AMEX:SYI	Synvista Therapeutics,
12/03/2009	18h48	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	AMEX:SYI	Synvista Therapeutics,
12/03/2009	11h03	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	AMEX:SYI	Synvista Therapeutics,
09/03/2009	17h25	Edgar (US Regulatory)	Withdrawal of Registration Statement (RW)	AMEX:SYI	Synvista Therapeutics,
09/03/2009	17h24	Edgar (US Regulatory)	-National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25)	AMEX:SYI	Synvista Therapeutics,
26/02/2009	19h00	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:SYI	Synvista Therapeutics,
24/02/2009	22h15	PR Newswire (US)	Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE	AMEX:SYI
28/01/2009	22h00	PR Newswire (US)	Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update	AMEX:SYI
12/01/2009	14h30	PR Newswire (US)	Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium	AMEX:SYI
24/12/2008	19h24	PR Newswire (US)	Synvista Notified by NYSE Alternext of Continued Listing Standards Non-Compliance	AMEX:SYI
16/12/2008	14h30	PR Newswire (US)	Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline	AMEX:SYI
15/12/2008	14h30	PR Newswire (US)	Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis	AMEX:SYI
03/12/2008	22h26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:SYI	Synvista Therapeutics,
19/11/2008	15h43	PR Newswire (US)	Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit	AMEX:SYI	Synvista Therapeutics,
14/11/2008	21h57	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:SYI	Synvista Therapeutics,
11/11/2008	14h30	PR Newswire (US)	Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA M	AMEX:SYI	Synvista Therapeutics,
10/11/2008	17h57	PR Newswire (US)	Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference	AMEX:SYI	Synvista Therapeutics,
10/11/2008	14h30	PR Newswire (US)	Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the Ameri	AMEX:SYI	Synvista Therapeutics,
24/10/2008	18h10	PR Newswire (US)	Synvista Therapeutics to Present at the 2008 BIO Investor Forum	AMEX:SYI	Synvista Therapeutics,
10/10/2008	22h19	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:SYI	Synvista Therapeutics,
10/10/2008	22h07	PR Newswire (US)	Synvista Therapeutics Appoints William Federici to its Board of Directors	AMEX:SYI	Synvista Therapeutics,
29/09/2008	15h03	PR Newswire (US)	Synvista Therapeutics Receives Approval to Begin Phase 2 Trial of Topical SYI-2074 in Psoriasis	AMEX:SYI	Synvista Therapeutics,
17/09/2008	19h27	PR Newswire (US)	Synvista Therapeutics Posts Letter to Stockholders on Web Site	AMEX:SYI	Synvista Therapeutics,
15/09/2008	15h15	PR Newswire (US)	Vista Partners Updates Coverage on Synvista Therapeutics, Inc. (Amex: SYI); Maintains $4.46 Target Price	AMEX:SYI	Synvista Therapeutics,
11/09/2008	14h00	PR Newswire (US)	Data Confirm Synvista Therapeutics Haptoglobin Diagnostic Test Kit Success in Rapidly Determining Cardiovascular Risk in Patient	AMEX:SYI	Synvista Therapeutics,
14/08/2008	15h29	Edgar (US Regulatory)	Synvista Therapeutics, Inc. - Quarterly Report (10-Q)	AMEX:SYI	Synvista Therapeutics,
25/07/2008	12h04	Edgar (US Regulatory)	Synvista Therapeutics, Inc. - Current report filing (8-K)	AMEX:SYI	Synvista Therapeutics,
24/07/2008	17h44	Edgar (US Regulatory)	Synvista Therapeutics, Inc. - Statement of Changes in Beneficial Ownership (4)	AMEX:SYI	Synvista Therapeutics,
06/06/2008	19h30	PR Newswire (US)	Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Dise	AMEX:SYI	Synvista Therapeutics,
04/06/2008	18h28	Edgar (US Regulatory)	Synvista Therapeutics, Inc. - Additional Proxy Soliciting Materials (definitive) (DEFA14A)	AMEX:SYI	Synvista Therapeutics,